Story highlights
The Food and Drug Administration approves the first drug for female sexual desire with caution
Flibanserin, which some call "female Viagra," is for treatment of hypoactive sexual desire disorder
The drug failed two times before it was recommended for approval in June
CNN
—
Women who have lost their sex drive will have a little pink pill to help them come October. On Tuesday, the U.S. Food and Drug Administration approved flibanserin, which will be sold as Addyi, for the treatment of sexual dysfunction in premenopausal women.
This is the first FDA approved treatment for sexual desire in men or women.